Detalhe da pesquisa
1.
Fulbright as Opportunity for U.S. Nursing Educators and International Nursing Schools.
J Nurs Educ
; : 1-4, 2024 Mar 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38536198
2.
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer.
Cell Chem Biol
; 30(10): 1191-1210.e20, 2023 10 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37557181
3.
Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors.
Bioorg Med Chem Lett
; 22(15): 5114-7, 2012 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22765900
4.
SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance.
Mol Cancer Ther
; 21(1): 3-15, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34737197
5.
Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance.
Mol Cancer Ther
; 15(10): 2273-2281, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27496135
6.
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models.
Cancer Cell
; 28(1): 70-81, 2015 Jul 13.
Artigo
Inglês
| MEDLINE | ID: mdl-26144315
7.
Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations.
J Med Chem
; 57(11): 4720-44, 2014 Jun 12.
Artigo
Inglês
| MEDLINE | ID: mdl-24819116
8.
Design of potent and selective inhibitors to overcome clinical anaplastic lymphoma kinase mutations resistant to crizotinib.
J Med Chem
; 57(4): 1170-87, 2014 Feb 27.
Artigo
Inglês
| MEDLINE | ID: mdl-24432909
9.
Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
J Med Chem
; 52(22): 7211-9, 2009 Nov 26.
Artigo
Inglês
| MEDLINE | ID: mdl-19873974